Skip to main content
. 2019 Jun 5;25:4193–4201. doi: 10.12659/MSM.914725

Table 3.

GAP data summary.

Variable GAP points No. of patients
Gender
 Female 0 27 (13.0)
 Male 1 180 (87.0)
Age, years
 ≤60 0 71 (34.3)
 61–65 1 33 (15.9)
 >65 2 103 (49.8)
Physiology
 FVC, %predicted
  >75 0 105 (50.7)
  50–75 1 80 (38.6)
  <50 2 22 (10.6)
 DLco, %predicted
  >55 0 86 (41.5)
  36–55 1 55 (26.6)
  <35 2 65 (31.4)
GAP stage
 Stage I 0–3 107 (47.5)
 Stage II 4–5 96 (42.6)
 Stage III 6–8 22 (9.9)